Author

L. Ferrer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1 Assay:metagenomics· 1

Frequent Co-Authors

A. Barreiro· 2 shared A. Fernandez· 2 shared A. Meyerhans· 2 shared C. Garriga· 2 shared E. Pradenas· 2 shared J. Blanco· 2 shared L. Gonzalez· 2 shared M. Canete· 2 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. Barreiro

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate

A. Moros, A. Prefaneta, A. Barreiro, E. Perozo, A. Fernandez, M. Canete, L. Gonzalez, C. Garriga, E. Pradenas, S. Marfil, J. Blanco, P. Cebollada-Rica, M. Sistere-Oro, A. Meyerhans, T. Prat Cabanas, , L. Ferrer

This study evaluates the immunogenicity and safety of PHH-1V, a SARS-CoV-2 RBD fusion vaccine in pigs, showing a robust immune response and good safety profile.

bioRxiv · Jan 19, 2023Immunology

Preclinical evaluation of PHH-1V vaccine candidate against SARS-CoV-2 in non-human primates

A. Prenafeta, G. Bech-Sabat, S. Moros, A. Barreiro, A. Fernandez, M. Canete, M. Roca, L. Gonzalez, C. Garriga, J. Confais, M. Toussenot, H. Contamin, A. Pizzorno, M. Rosa-Calatrava, E. Pradenas, , L. Ferrer

This study evaluates the PHH-1V vaccine candidate against SARS-CoV-2 in non-human primates, showing high antibody levels, balanced cellular immunity, and reduced viral load.

bioRxiv · Dec 13, 2022Immunology

Dysbiosis in a canine model of human fistulizing Crohn’s disease

A. Maldonado-Contreras, L. Ferrer, C. Cawley, S. Crain, J. Toscano, D. V. Ward, A. Hoffman

The paper compares gut microbiomes of dogs with canine anal furunculosis to healthy dogs, finding similarities to human Crohn’s disease microbiomes and supporting dogs as a model for studying fistulizing CD.

bioRxiv · Oct 22, 2019Microbiology